期刊文献+

155例肿瘤患者癌性贫血的相关因素分析 被引量:8

Related factors analysis of cancer anemia in 155 tumor patients
下载PDF
导出
摘要 目的:观察化疗及其他因素对肿瘤患者血红蛋白(HGB)的影响。方法:选择我科2011年10月-2014年10月收治的155例肿瘤患者。统计性别、年龄、原发肿瘤、临床分期、分化程度、治疗方案、各周期化疗前后谷丙转氨酶、谷草转氨酶、血肌酐、血红蛋白值等资料;采用SPSS 19.0软件进行单因素分析及多因素Logistic分析,得出癌性贫血的独立危险因素。结果:肿瘤患者血红蛋白值化疗后呈逐渐下降趋势,第5个周期化疗后降至最低。化疗前,性别、年龄和肾功能是否异常是癌性贫血的相关因素,其中,女性、65岁以上和肾功能异常是独立危险因素;第1个周期化疗后,性别和肾功能是否异常是癌性贫血的相关因素,其中,女性和肾功能异常是独立危险因素;第5个周期化疗后,性别、病种、化疗方案和肾功能是否异常是癌性贫血的相关因素,但均不是独立危险因素。结论:老年女性、肾功能异常的肿瘤患者更易发生癌性贫血,应采取预防措施及适当的对症治疗。 Objective: To observe the effect of chemotherapy and other factors on hemoglobin of tumor patients.Methods: To choose 155 tumor patients and collect the data included gender,age,primary tumor,pathological staging,degree of differentiation,ALT,AST,serum creatinine,hemoglobin before and after each cycle of chemotherapy. To use single factor analysis by SPSS 19. 0 software and multivariate Logistic analysis to obtain the independent risk factors of cancer anemia. Results: Patients’ hemoglobin in pre- chemotherapy and 1st ~ 5th chemotherapy cycle gradually declined,and fell to the lowest after 5th chemotherapy cycle. Before chemotherapy,gender,age and kidney function decreasion were related factors of cancer anemia,and women,over the age of 65,kidney function decreasion were independent risk factors. After 1st chemotherapy cycle,gender and kidney function decreasion were related factors of cancer anemia,women and kidney function decreasion were independent risk factors. Conclusion: Elderly women,kidney function decreasion were more susceptible to cancer anemia.
出处 《现代肿瘤医学》 CAS 2016年第5期782-786,共5页 Journal of Modern Oncology
基金 辽宁省自然科学基金(编号:2014021032)
关键词 癌性贫血 化疗 相关因素分析 危险因素 cancer-related anemia chemotherapy related factors analysis risk factor
  • 相关文献

参考文献22

  • 1Cella,D.Quality of life and clinical decisions in chemotherapy-induced anemia. Oncology (Williston Park) . 2006
  • 2Edesa WA1,Abdelmalek RR.Efficacy and toxicity of sunitinib in metastatic renal cell carcinoma patients in egypt.. Asian Pacific Journal of Cancer Prevention . 2015
  • 3Pettengell R,Silvestre AS,Schwenkglenks M.Darbepoetin alfa administration in patients with non-Hodgkin lymphoma and chemotherapy-induced anemia receiving (±R)CHOP. Hematology . 2013
  • 4Gilreath JA,Rodgers GM.Current quandaries in cancer-associated anemia. J Natl Compr Canc Netw . 2014
  • 5Del Giudice ME,Vella ET,Hey A.Systematic review of clinical features of suspected colorectal cancer in primary care. Canadian Family Physician . 2014
  • 6Zhang BY,Wang YM,Gong H.Isorhamnetin flavonoid synergistically enhances the anticancer activity and apoptosis induction by cis-platin and carboplatin in non-small cell lung carcinoma (NSCLC). Int J Clin Exp Pathol . 2015
  • 7Zhao X,Zhao Z,Xu W.Down-regulation of miR-497 is associated with poor prognosis in renal cancer. Int J Clin Exp Pathol . 2015
  • 8Binay Kumar Shah,Dipesh Uprety,David Tretheway.??Multiple Myeloma Presenting with Autoimmune Hemolytic Anemia(J)Indian Journal of Hematology and Blood Transfusion . 2014 (1)
  • 9Sharon Lim,Yin Zhang,Danfang Zhang,Fang Chen,Kayoko Hosaka,Ninghan Feng,Takahiro Seki,Patrik Andersson,Jingrong Li,Jingwu Zang,Baocun Sun,Yihai Cao.??VEGFR2-Mediated Vascular Dilation as a Mechanism of VEGF-Induced Anemia and Bone Marrow Cell Mobilization(J)Cell Reports . 2014 (2)
  • 10Pere Gascón,César A. Rodríguez,Vicente Valentín,Jesús García Mata,Joan Carulla,Javier Cassinello,Ramón Colomer,Eva Baró.??Usefulness of the PERFORM questionnaire to measure fatigue in cancer patients with anemia: a prospective, observational study(J)Supportive Care in Cancer . 2013 (11)

共引文献2

同被引文献70

引证文献8

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部